Cart
sales@molnova.com
Baccatin III
CAS No. 27548-93-2
Baccatin III ( —— )
Catalog No. M18350 CAS No. 27548-93-2
Baccatin III is an isolate of the Pacific yew tree (Taxus brevifolia) and related species. Baccatin III is a precursor to the anti-Y drug paclitaxel (Taxol).
Purity : 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 41 | Get Quote |
|
| 10MG | 69 | Get Quote |
|
| 25MG | 125 | Get Quote |
|
| 50MG | 201 | Get Quote |
|
| 100MG | 339 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameBaccatin III
-
NoteResearch use only, not for human use.
-
Brief DescriptionBaccatin III is an isolate of the Pacific yew tree (Taxus brevifolia) and related species. Baccatin III is a precursor to the anti-Y drug paclitaxel (Taxol).
-
DescriptionBaccatin III is an isolate of the Pacific yew tree (Taxus brevifolia) and related species. Baccatin III is a precursor to the anti-Y drug paclitaxel (Taxol).
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number27548-93-2
-
Formula Weight586.64
-
Molecular FormulaC31H38O11
-
Purity98%
-
Solubility——
-
SMILESO([C@]12[C@@H]3[C@](C(=O)[C@H](OC(=O)C)C4=C([C@@H](O)C[C@@](O)([C@H]3OC(=O)c3ccccc3)C4(C)C)C)([C@@H](O)C[C@H]1OC2)C)C(=O)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Han F, et al. J Sci Food Agric, 2014, 94: 2376–2383.
molnova catalog
related products
-
Tridecane
n-Tridecane is both a stress compound released by the brown marmorated stink bugs and an volatile oil component isolated from essential oil of Piper aduncum L. Tridecane.
-
Dihydrorhodamine 123
Dihydrorhodamine 123 is a fluorescent probe.
-
Ginsenoside Ra1
Ginsenoside Ra1 is a component from ginseng. Ginsenoside Ra1 shows significant inhibitory effects on protein tyrosine kinase (PTK) activation induced by hypoxia/reoxygenation (H/R).
